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ScienceDirectThe Jumonji-C (JmjC) subfamily of 2-oxoglutarate (2OG)-
dependent oxygenases are of biomedical interest because of
their roles in the regulation of gene expression and protein
biosynthesis. Human JmjC 2OG oxygenases catalyze oxidative
modifications to give either chemically stable alcohol products,
or in the case of Ne-methyl lysine demethylation, relatively
unstable hemiaminals that fragment to give formaldehyde and
the demethylated product. Recent work has yielded conflicting
reports as to whether some JmjC oxygenases catalyze
N-methyl group demethylation or hydroxylation reactions. We
review JmjC oxygenase-catalyzed reactions within the context
of structural knowledge, highlighting key differences between
hydroxylases and demethylases, which have the potential to
inform on the possible type(s) of reactions catalyzed by partially
characterized or un-characterized JmjC oxygenases in humans
and other organisms.
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Introduction
Interest in human Fe(II)- and 2-oxoglutarate (2OG)-de-
pendent oxygenases has been stimulated by the discovery
of their roles in regulation of gene expression and protein
biosynthesis. More than 60 human 2OG oxygenases have
been identified, with roles in diverse processes such as
fatty acid metabolism (including carnitine biosynthesis),
collagen biosynthesis, development, and the hypoxicCurrent Opinion in Structural Biology 2016, 41:62–72 response [1]. Of these, the Jumonji-C domain-containing
oxygenases (JmjC oxygenases) have attracted attention,
including from a pharmaceutical perspective [2], principally
because of their roles in histone demethylation [3,4,5,6],
though they have wider roles in protein hydroxylation
[7,8,9]. The JmjC oxygenases are a subfamily of 2OG
oxygenases that share sequence homology and structural
similarities (as detailed below). Most JmjC oxygenases
(>20) have been assigned as histone lysine demethylases
(KDMs), which catalyze Ne-methyl lysine residue demeth-
ylation reactions (Figure 1a), proceeding via initial Ne-
methyl group hydroxylation followed by fragmentation to
give the demethylated product and formaldehyde. Other
members of the JmjC subfamily catalyze oxidation of
proteins (and, in one case, tRNA) to give a stable hydroxyl-
ated product; we refer to these as ‘JmjC hydroxylases’. This
dual functionality within the JmjC subfamily has led to
conflicting reports regarding the assignment of some JmjC
oxygenases. To date, several JmjC oxygenases have been
reported to catalyze both demethylation and hydroxylation.
Here, we review JmjC oxygenases from structural and
biochemical perspectives, focusing on members that have
been structurally characterized. We discuss structural
features common to different types of JmjC oxygenases
(i.e. hydroxylases versus demethylases) and correlate these
with the types of reactions that they catalyze.
History and overview of the JmjC oxygenases
The JmjC domain is named after the ‘Jumonji’ protein in
which it was first identified [10]. The name ‘Jumonji’
(meaning ‘cruciform’ in Japanese) is based on the abnor-
mal ‘cross-like’ appearance of neural grooves in Jumonji
(Jmj)-null mice. The Jmj gene was proposed to encode for
a putative Jumonji protein (corresponding to human
JARID2) [10], which contains a DNA-binding domain
(AT-rich interaction domain, ARID), JmjC, and Jumonji-
N (JmjN) domains [11]. The latter two were proposed to
co-occur [11], though later work revealed they are sepa-
rate structural and functional units [12]. Bioinformatics
indicated that the JmjC domain is widely distributed in
eukaryotes [11,12]. Since many of the proteins containing
JmjN and JmjC domains had been previously linked with
transcriptional control and contained known DNA bind-
ing domains (e.g. plant homeobox domain (PHD), ARID,
or Zn fingers), they were collectively termed the Jumonji
family of transcription factors [11]. Bioinformatics identi-
fied that the JmjC domain shared considerable similaritywww.sciencedirect.com
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Characteristic features of JmjC domain architecture and reaction catalysis. (a) Demethylation and hydroxylation reactions catalyzed by human
JmjC oxygenases. (b) (Left) View from a crystal structure of an FIH monomer (PBD ID: 1H2K, [14]) as a representative JmjC oxygenase, and
(right) two dimensional domain topology of a generalized JmjC domain (generated using TopDraw). The JmjC domain fold contains a distorted
double-stranded b-helix (DSBH; b-strands I–VIII; blue) fold, additional N-terminal anti-parallel b-strands that extend the DSBH (grey), and a bIV-V
insert (red). Fe(II) (orange sphere) and 2OG (cyan sticks) are bound in the active site. Abbreviations are defined in Table 1.with enzymes containing a cupin or double-stranded b-
helix (DSBH) fold, leading to the proposal that JmjC
proteins act as Zn(II)-dependent transcriptional regula-
tors, since phosphomannose isomerase is a Zn(II)-utiliz-
ing DSBH fold enzyme [12].
Studies on the first biochemically and structurally charac-
terized JmjC oxygenase, factor inhibiting hypoxia induciblewww.sciencedirect.com factor (FIH), reveal the JmjC domain indeed adopts a
DSBH fold [7,8,13,14,15]. Rather than supporting a
Zn(II)-binding active site, FIH is an Fe(II)- and 2OG-
dependent oxygenase like many JmjC enzymes. This work
identified roles for JmjC oxygenases in transcriptional reg-
ulation via FIH-catalyzed asparaginyl hydroxylation of
hypoxia inducible factor-a (HIF-a) isoforms [7,8], a reac-
tion important in the hypoxic response; FIH regulates HIFCurrent Opinion in Structural Biology 2016, 41:62–72
64 Catalysis and regulationactivity by reducing its binding to transcriptional coactiva-
tors (CBP/p300) [16]. These discoveries were followed by
important work identifying the first JmjC domain-contain-
ing KDMs, that is the KDM2, 3, and 4 subfamilies [3,4,5].
These studies expanded roles of JmjC oxygenase catalysis
to ‘epigenetic’ regulation and identified JmjC KDMs as the
largest class of histone KDMs [6], with the flavin-depen-
dent lysine specific KDMs constituting a smaller class [17].
Structural studies of the JmjC catalytic core of KDM4A
provided the first insights into KDM structure–function
relationships [18,19,20]. Since the identification of FIH
and the first JmjC KDMs, the substrate repertoire of JmjC
oxygenases has expanded to include other KDMs acting on
histone tails [6], multiple non-HIF-a FIH substrates (most-
ly ankyrin repeat domain proteins) [21], mRNA splicing
factors [22], tRNA [23], ribosomal proteins [24], and
other proteins involved in translation [25] (Table 1). These
discoveries reveal 2OG oxygenase-catalyzed hydroxylation
of proteins is more extensive than was perceived before the
identification of JmjC oxygenases [9].
There are controversies regarding functional assignments
of some JmjC oxygenases: Jumonji domain-containing 6
(JMJD6) is proposed to catalyze both N-methyl argininyl
demethylation and lysyl hydroxylation [22,26,27–29],
the ribosomal oxygenases (ROXs), MYC-induced nuclear
antigen 53 (MINA 53) and nucleolar protein 66 (NO66)
are assigned as both KDMs [30,31] and ribosomal protein
hydroxylases [24], and there are conflicting proposals for
Jumonji domain-containing 5 (JMJD5) as either a KDM
or hydroxylase [32,33].
JmjC domain architecture and catalysis
All structurally characterized 2OG oxygenases, including
JmjC oxygenases, possess a distorted DSBH core fold
comprising eight anti-parallel b-strands (labeled I–VIII
in Figure 1b; Supplementary Figure 1) [34]. The DSBH
fold characterizes both cupin and JmjC proteins; the
different nomenclature has emerged likely for historical
reasons. Note there is no absolute definition of a JmjC
protein; however, detailed bioinformatics has previously
highlighted sequence and structural features that distin-
guish the JmjC oxygenases from the larger 2OG oxygenase
superfamily [35].
The asymmetric, barrel-like DSBH fold of 2OG oxyge-
nases is formed from long b-strands I, VIII, III and VI
(major b-sheet) on one face and short b-strands II, VII, IV
and V (minor b-sheet) on the other (Figure 1b). The
DSBH supports several conserved active site residues
including those binding Fe(II) and 2OG. Fe(II) is nor-
mally, but not always, bound by an HxD/E  H triad, in
which Asp is more common than Glu; the only human
JmjC oxygenases with a Glu residue are KDM4 and
KDM6 subfamily members and JMJD1C [34,36]. The
first His of the triad is situated at the end of bII, with the
Asp/Glu normally located on the bII/bIII loop, while theCurrent Opinion in Structural Biology 2016, 41:62–72 ‘distal’ His is positioned at the start of bVII, spatially
adjacent to bII (Figure 1b). 2OG binds to Fe(II) in a
bidentate manner via its C-2 keto and C-1 carboxylate
groups (Supplementary Figure 2A); its binding is stabi-
lized by electrostatic and hydrogen bonding interactions,
including between its C-5 carboxylate and a basic residue
located deeper in the DSBH. For human JmjC oxyge-
nases, this residue is typically a lysine located at the bIV
N-terminus. Exceptions to this include the KDM6 sub-
family [37–39], where the lysine is on bI, and KDM3B,
where the lysine is on bVIII (PBD ID: 4LXL). The
bacterial JmjC hydroxylase ycfD is the only structurally
characterized JmjC oxygenase with an arginine rather
than a lysine residue on the bIV strand [40,41], a differ-
ence proposed to reflect changes in JmjC evolution [41].
As for other 2OG oxygenases, the JmjC oxygenases
appear to use an ordered sequential mechanism, where
2OG binding is followed by substrate and, finally, O2
(Supplementary Figure 2B) [42]. Oxygen binding enables
2OG decarboxylation (giving succinate and CO2), yield-
ing a reactive Fe(IV) O species that effects substrate
oxidation [42]. In the case of N-methyl demethylation,
hydroxylation results in a hemiaminal, which fragments
to form the demethylated product and formaldehyde
[3,5,43]. Release of the hydroxylated/demethylated
product and succinate completes the cycle [42]. While
the overall 2OG oxygenase superfamily catalyzes a very
diverse set of reactions [1], JmjC catalysis is currently
limited to hydroxylation and demethylation (Figure 1a) [9].
Overall domain architecture and roles of non-
catalytic domains
Though the JmjC oxygenases have conserved catalytic
domains, their overall architectures vary. Most JmjC
KDMs have multiple domains and are typically 2–3 times
longer than the JmjC hydroxylases (Table 1). The addi-
tional non-catalytic domains in KDMs are subfamily-
characteristic histone-binding and nucleic acid-binding
domains, some of which enable targeting to specific (sets
of) histone modifications. For example, KDM7B-cata-
lyzed demethylation of di/monomethylated histone H3
lysine-9 (H3K9me2/1) is strongly promoted by pi-cation-
pi/hydrophobic interactions between an aromatic cage in
its PHD domain and H3K4me3 [44] (Figure 2). In the
case of KDM4A, which catalyzes demethylation of
H3K9me3/2, H3K36me3/2, and H1.4K26me3/2, its tudor
domains bind histones via interactions between an aro-
matic cage and H3K4me3 and H4K20me3 sites [45–47].
The JmjC hydroxylases appear to lack chromatin-associ-
ated domains, but they have other domains/regions, such
as dimerization and winged-helix (WH) domains
(Table 1), that can be involved in substrate binding. A
hydrophobic region in the FIH dimerization domain
promotes HIF-a substrate binding (Figure 2) [14]. Simi-
larly, the dimerization domain of the JmjC nucleic acid
hydroxylase, tRNA wybutosine-synthesizing protein 5
(TYW5), is proposed to play a role in tRNA binding, inwww.sciencedirect.com
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Table 1
Reported biochemical functions of human JmjC oxygenases.
Subfamily Name Other Names NCBI/UniProt ID Catalytic Function
Reported Biochemical & 
Cellular Substrate(s) Domain Architecture
†
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s
KDM2
(FBXL)
KDM2A* FBXL11; JHDM1A 22992/Q9Y2K7 Lys(me2/1) demethylase H3K36, p65 
KDM2B FBXL10; JHDM1B 84678/Q8NHM5 Lys(me2/1) demethylase H3K36, H3K4me3
KDM3 
(JMJD1)
KDM3A* JMJD1A; JHDM2A 55818/Q9Y4C1 Lys(me2/1) demethylase H3K9
KDM3B JMJD1B; JHDM2B 51780/Q7LBC6 Lys(me2/1) demethylase H3K9
JMJD1C - 221037/Q15652 Lys(me2/1) demethylase H3K9, MDC1
KDM4 
(JMJD2)
KDM4A* JMJD2A; JHDM3A 9682/O75164 Lys(me3/2/1) demethylase H3K9, H3K36, H1.4K26
KDM4B JMJD2B; JHDM3B 23030/O94953 Lys(me3/2/1) demethylase H3K9, H3K36, H1.4K26
KDM4C JMJD2C; JHDM3C 23081/Q9H3R0 Lys(me3/2/1) demethylase H3K9, H3K36, H1.4K26; Pc2
KDM4D* JMJD2D; JHDM3D 55693/Q6B0I6 Lys(me3/2/1) demethylase H3K9, H3K36, H1.4K26
KDM4E JMJD2E 390245/B2RXH2 Lys(me3/2/1) demethylase H3K9
KDM5
(JARID)
KDM5A*
KDM5B
KDM5C
KDM5D
JARID1A; RBP2
JARID1B; PLU1
JARID1C; SMCX
JARID1D; SMCY
5927 P29375
10765/Q9UGL1
8242/P41229
8284/Q9BY66
Lys(me3/2/1) demethylase H3K4
KDM6
KDM6A* UTX 7403/O15550 Lys(me3/2/1) demethylase H3K27
KDM6B JMJD3 23135/O15054 Lys(me3/2/1) demethylase H3K27
KDM6C UTY 7404/O14607 Lys(me3/2/1) demethylase H3K27
KDM7
KDM7A KIAA1718; JHDM1D 80853/Q6ZMT4 Lys(me2/1) demethylase H3K9, H3K27, H4K20
KDM7B* PHF8;  JHDM1F 23133/Q9UPP1 Lys(me2/1) demethylase H3K9, H4K20
KDM7C PHF2; JHDM1E 5253/O75151 Lys(me2/1) demethylase H3K9, H3K27, H4K20me3, ARID5B
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JmjC-only
JMJD6 - 23210/Q6NYC1
Lys (5S )-hydroxylase;
Arg(me1) demethylase**
Splicing proteins (e.g. 
U2AF65, LUC7L2), p53
H3R2**;  H4R3**
MINA53 MINA 84864/Q8IUF8 His (3S )-hydroxylase;Lys(me3/2) demethylase** RPL27; H3K9**
NO66 - 79697/Q9H6W3 His 3S -hydroxylase;Lys(me3/2) demethylase** RPL8; H3K4**, H3K36**
JMJD5 KDM8 79831/Q8N371 Lys(me2) demethylase**Hydroxylase**
H3K36**
NFATc1**
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JmjC-only
FIH HIF1AN 55662/Q9NWT6 Asn (3S )-hydroxylase;Asp/His (3S )-hydroxylase
HIF-1α;
Multiple ankryin repeat domain
proteins 
JMJD4 - 65094/Q9H9V9 Lys C-4 hydroxylase eRF1
TYW5 - 129450/A2RUC4 Wybutosine β-hydroxylase  tRNA (yW -72)
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ed
 
Jm
jC
 ox
yg
en
as
es
JmjC-only
HSPBAP1 PASS1 6767/Q96EW2 n/d n/d
JMJD7 - 100137047/P0C870 n/d n/d
JMJD8 - 339123/Q96S16 n/d n/d
JmjC JmjN F-box LRR CXXC Zn Finger C6 Zn Finger PHD Zn Finger ARID TPR Tudor Dimerization WH
* Subfamily domain architecture representation is based on this enzyme.
** Controversial functional assignments.
y Domain architecture based on reported domains as defined by PROSITE-ProRule [74] or structures (MINA53 [41], FIH [14], and TYW5 [48]).
z KDM6B does not have reported TPR domains, though is roughly the same size as KDM6A and KDM6C.
Abbreviations (alphabetical): ARID, AT-rich interaction domain; eRF1, eukaryotic release factor 1; FBXL10/11, F-box and leucine-rich repeat protein
10/11; FIH, factor inhibiting HIF-1a; HIF-1a, hypoxia inducible factor 1-alpha; HIF1AN, hypoxia inducible factor 1-alpha inhibitor; HSPBAP1, heat
shock 27 kDa associated protein 1; JARID, Jumonji/AT-rich interaction domain-containing protein; JHDM, Jumonji-C domain-containing histone
demethylase; JmjC, Jumonji-C; JMJD, Jumonji domain-containing; JmjN, Jumonji-N; KDM, lysine-specific demethylase; LRR, leucine rich repeat;
LUC7L2, LUC7-like 2 pre-mRNA splicing factor; MDC1, mediator of DNA-damage checkpoint 1; MINA(53), MYC-induced nuclear antigen (53);
NFATc1, nuclear factor of activated T-cells calcineurin-dependent 1; NO66, nucleolar protein 66; OHyW, hydroxywybutosine; p65, nuclear factor NF-
kappa-B p65 subunit; PHD, plant homeobox domain; PHF2/8, plant homeobox domain finger protein 2/8; RBP2, retinoblastoma binding protein 2;
RPL8/27, 60S ribosomal protein L8/27; TPR, tetratricopeptide repeat; TWY5, tRNA wybutosine-synthesizing protein 5; UTX/Y, ubiquitously
transcribed tetratricopeptide repeat, X/Y chromosome; U2AF65, U2 small nuclear ribonucleoprotein auxiliary factor 65-kDa subunit; WH,
winged-helix; yW-72, 7-(a-amino-a-carboxypropyl)wyosine.part via a positively charged patch formed by C-terminal
a-helices [48]. In the case of the ROXs, substrate bind-
ing is facilitated by the subfamily-characteristic C-termi-
nal WH domain (Figure 2) [41].
JmjC protein oligomerization
One difference observed between JmjC hydroxylases and
KDMs is that the former oligomerize, usually as dimers,
in a catalytically important manner (Supplementarywww.sciencedirect.com Figure 3) [41,49–51]. The FIH dimer interface is formed
by four C-terminal a-helices (two from each monomer),
which interlock primarily via hydrophobic interactions
[49]. TYW5 also dimerizes via a C-terminal a-helix bun-
dle [48], though the anti-parallel orientation of its
a-helical arrangement distinguishes it from FIH dimer-
ization. The human and bacterial ROXs have conserved
dimerization domains, but these are located between
their JmjC and WH domains [40,41,51].Current Opinion in Structural Biology 2016, 41:62–72
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Figure 2
Current Opinion in Structural Biology
NOG
Y7
I43
R42
JmjC domain
C
N C
FIH
N
PHD finger JmjC domain
KDM7B C
JmjC domain
JmjC domain
C
H3K9me2
N
C
N
W29
Y14
H3K4me3
PHD-type zinc finger
KDM4A
double tudor domainPHD fingerJmjC domainJmjN domain
N C
JmjN domain
C
N
Y973
C
tudor-domain
MINA53 JmjC domain WH-domain
dimerization domain
JmjC domain dimerization domain
C
N
CC
N
N
HIF-1 α
dimerization domainwinged-helix domain
NOG
JmjC domain
Mn
H39
N
rpL27A
Comparison of domain architecture and substrate binding between JmjC KDMs and hydroxylases. (Upper panel) Views from structures of KDM7B
complexed with a H3K9me2K4me3 peptide fragment (PBD ID: 3KV4, [44]), KDM4A complexed with a H3K9me3K14Ac peptide fragment (PBD ID:
2OQ6, [20]), and KDM4A double tudor domains complexed with H3K4me3 peptide fragment (PDB ID: 2GFA, [45]). Zoomed views highlight key
substrate binding interactions with active sites, the PHD non-catalytic domains of KDM7B, and the JmjN and double tudor non-catalytic domains
of KDM4A. (Lower panel) Views from structures of MINA53 complexed with RPL27A peptide fragment (PBD ID: 4BXF, [41]) and FIH complexed
with a HIF-1a peptide fragment (PBD ID: 1H2K, [14]). Zoomed views highlight key substrate interactions in the active site and the non-catalytic
Current Opinion in Structural Biology 2016, 41:62–72 www.sciencedirect.com
Structure–function relationships of JmjC oxygenases Markolovic et al. 67JMJD6 oligomerization is more complex than for other
studied hydroxylases. Structures for truncated JMJD6
present both dimeric and monomeric forms [52,53],
though these do not fully reflect JMJD6 oligomerization.
In solution, recombinant JMJD6 adopts different oligo-
meric states, including monomeric, trimeric, pentameric
and larger oligomeric forms [54–57]. JMJD6 oligomeriza-
tion, which is affected by the presence/absence of its
polyserine domain, is proposed to play a role in both
catalysis and subcellular localization of JMJD6 [55].
JMJD6, like TYW5, has a positively charged surface
patch, which may enable RNA binding [53].
Despite its assignment as a KDM [32], JMJD5 more
closely resembles the JmjC hydroxylases (see below).
Structures of N-terminally truncated JMJD5 constructs
reveal that the DSBH is located immediately at the C-
terminus [50,58]; yet, N-terminally truncated JMJD5
exists in both monomeric and dimeric oligomerization
states in solution [58], suggesting JMJD5 oligomerizes via
a different mode than FIH and TYW5 [14,48,49].
In contrast to the hydroxylases, KDM oligomerization is
not well characterized, likely in part due to their size and
typical multi-domain architecture. Currently, there are
only crystal structures for truncated JmjC KDM constructs,
none of which reveal oligomerization. Yet, solution studies
indicate full-length KDM3A forms a homodimer via
interactions between a Zn finger motif and its JmjC domain
[59]. In the case of the KDM4 subfamily, cell-based
immunoprecipitation experiments suggest that full-length
KDM4A, C, and D are capable of forming homo-oligomers,
while KDM4A/C can hetero-oligomerize [60].
JmjC active site substrate binding
Differences in substrate binding within their active sites
distinguish JmjC KDMs from hydroxylases. To accom-
modate Ne-methylated lysine residues, the KDMs tend to
have a deeper and sometimes narrower substrate binding
pocket than the hydroxylases (Figure 3a). The KDMs
typically have a hydrophobic region in their active site
(e.g. as formed by V231, Y234, L236, F250, G331, and
N333 in KDM7B), which interacts with the hydrophobic
Ne-methyl lysine side chain and Ne-methylated group
(Figure 3b) [44]. While such hydrophobic interactions
are generally characteristic of KDMs, there are variations
in the modes of substrate binding/recognition between
KDM subfamilies. For example, KDM2A and KDM7B
appear to adopt a binding mode that positions the target
Ne-methyl lysine residue within a relatively deep and
narrow binding pocket [44,61]. In contrast, KMD4A and
KDM6A adopt a binding mode where the substrate binds(Figure 2 Legend Continued) winged-helix (WH) domain of MINA53 and th
as green sticks. Note in some cases, Mn(II)/Ni(II) substitutes for Fe(II) and N
crystallographically stable complexes. Abbreviations are defined in Table 1.
www.sciencedirect.com more on the surface of the protein, and the target Ne-
methyl lysine residue binds in a relatively open pocket
[20,37]. Although other factors are likely involved, it is
possible that the apparently more spacious binding pock-
ets of the KDM4/KDM6 subfamilies enables them to
accommodate the more bulky trimethylation state
[20,37], which the KMD2/KMD7 subfamilies do not
accommodate [61,62] (though KDM2A has been crystal-
lized with a non-substrate trimethyllysine residue in its
active site [61]).
JmjC hydroxylases in general appear to have more open
binding sites than the KDMs (Figure 3a). Further, they
bind their target residues primarily through main and side
chain hydrogen bonds, rather than the principally hydro-
phobic interactions used by KDMs (Figure 3b). Such
binding is proposed to enable stereoselective hydroxylation
[14]. Stereoselectivity is likely not so important with
KDMs because methyl group oxidation leads to achiral
formaldehyde. KDMs also (normally) catalyze sequential
demethylations [63]; the hydrophobic interactions involved
in KDM substrate residue binding may enable flexibility,
which is undesirable in stereoselective hydroxylase cataly-
sis. Interestingly, the coordination position from which the
Fe(IV) O species reacts appears to vary with the JmjC
hydroxylases (e.g. it is different for the FIH-catalyzed Asn
hydroxylation compared to ROX-catalyzed His hydroxyl-
ation) [41], a difference proposed to reflect a branchpoint
in JmjC oxygenase evolution, with the ROXs being closer
to the KDMs than other hydroxylases (e.g. FIH) [41].
Another typical difference in active site substrate binding
between JmjC hydroxylases and KDMs is the presence of
an extended flexible loop region, immediately N-terminal
to bI of the DSBH, that is involved in binding target Ne-
methylated lysine residues (Figure 3c). For KDM7B, this
loop (residues 221–234) contains V231 and Y234, which
form stabilizing hydrophobic interactions with the target
residue as described above. This loop is observed to be
involved in substrate binding in substrate-bound crystal
structures of KDM2A, KDM4A, and KDM6A [20,37,61].
However, hydroxylases tend to lack this extended loop, as
exemplified by FIH (Figure 3c) [14]. The available
evidence is that hydroxylases bind their substrates with
an (approximately) conserved N-to-C directionality with
respect to their active site, whereas substrate binding
directionality appears more variable for the KDMs [41].
Controversial assignments of JmjC
oxygenases
Some JmjC oxygenases are assigned as both KDMs and
hydroxylases. These include the histidinyl hydroxylasese dimerization domain of FIH. Substrate peptide fragments are shown
-oxalylglycine (NOG) substitutes for 2OG in order to enable
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Figure 3
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Current Opinion in Structural Biology
Structural comparisons of active site accessibility/interactions and substrate recognition/binding of JmjC oxygenases. Comparison of structures of
FIH complexed with the C-terminal transactivation domain HIF-1a peptide fragment (PBD ID: 1H2K, [14]) and KDM7B complexed with an
H3K9me2 peptide fragment (PBD ID: 3KV4, [44]). (a) Surface views of FIH and KDM7B reveal differences in the active site topologies/
accessibilities of hydroxylases compared to KDMs. The available evidence is hydroxylases (left) have a relatively shallow, wide/open active site
whereas KDMs (right) generally have a relatively narrow, deep active site. (b) Comparison of substrate interactions as shown by stick
representations of key residues of FIH (black) and KDM7B (white). KDMs (right) tend to have a hydrophobic active site region, formed by V231,
Y234, L236, F250, G331, and N333 in KDM7B, important in binding the Ne-methylated lysine. Hydroxylases (left) bind their substrates by both
main and side chain hydrogen bonds. FIH and KDM7B active sites are overlaid in a central box. (c) The role of an extended flexible loop (red),
situated N-terminal to b1 of the DSBH, in substrate binding. This extended flexible loop tends to play an important role in KDM active site
Ne-methylated lysine binding, as exemplified by the loop in KDM7B (right). In contrast, the hydroxylases tend to lack (or have a much shorter)
extended flexible loop as shown by FIH (left). Note that JMJD6 is an exception (see main text). Substrate peptide fragments are shown as green
sticks. Abbreviations are defined in Table 1.
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[30,31], though later shown to catalyze (3S)-histidinyl
hydroxylation of ribosomal proteins RPL27a and
RPL8, respectively [24]. While it is possible MINA53
and NO66 have dual functions, independent attempts to
confirm their KDM activity using MS-based assays have
not yielded results supporting this assignment [24,64].
Further, structural characterizations support the assign-
ment of the human ROXs as hydroxylases, for reasons
including (i) the presence of a dimerization domain, (ii)
that their active sites are relatively open, (iii) that their
substrates are bound by polar/hydrogen bonding interac-
tions that enable stereoselective hydroxylation, (iv) clear
homology with the prokaryotic protein hydroxylase ycfD
and (v) the lack of an extended flexible KDM substrate
binding loop N-terminal to DSBH b1 typically observed
in KDMs (Supplementary Figure 1) [24,41,51]. JMJD6
likely has the most conflicting reports of any JmjC oxy-
genase. JMJD6 was initially (likely) mis-assigned as the
phosphatidylserine receptor [65]. It was subsequently
characterized as a histone N-methyl arginyl demethylase
acting on H3R2me1 and H4R3me1 [26], then as a lysyl
hydroxylase acting on splicing-associated proteins (e.g.
U2AF65 and LUC7L2) and histones [22,27,28]. JMJD6
is also reported to act on other proteins, including via lysyl
hydroxylation of p53 [66]. Evidence for ‘precise’ hydrox-
ylase-type catalysis by JMJD6 comes from studies on the
stereochemistry of its catalysis. This work reveals pro-
duction of (5S)-hydroxylysine [27], contrasting with the
other reported lysyl C-5 hydroxylase, procollagen lysyl
hydroxylase, which catalyses production of the (5R)-hy-
droxylated product [67]. As yet, there are no reports of
JMJD6 substrate complex structures, but the available
evidence implies JMJD6 is more similar to the JmjC
hydroxylases than KDMs based on (i) closer sequence
similarity to the JmjC hydroxylases, (ii) its ability to
oligomerize, (iii) its relatively open active site, and (iv)
topological similarity with some JmjC hydroxylases (Sup-
plementary Figure 1) [14,41,48]. Interestingly, JMJD6
contains an extended flexible loop immediately N-termi-
nal to DSBH bI [52,53], which is typically observed in
KDMs, and so the possibility that it also functions as a
demethylase cannot be ruled out. A detailed review of
JMJD6 is given by Bo¨ttger et al. [68]. Although JMJD5 is a
reported KDM [32], several studies have been unable to
demonstrate JMJD5-catalyzed demethylation [33,50,58].
Structural analyses of JMJD5, as given here and by others,
imply JMJD5 likely functions as a hydroxylase due to
structural similarities with TYW5 and FIH (Supplemen-
tary Figure 1) [50,58]. However, no direct hydroxylation
activity has yet been reported, though NFATc1 (nuclear
factor of activated T-cells calcineurin-dependent 1) is
proposed as a JMJD5 substrate [33].
Some JmjC oxygenases are proposed to be ‘pseudo’
enzymes, that is they are closely related to demonstrated
enzymes, but are catalytically inactive. In some predictedwww.sciencedirect.com JmjC proteins, the HxD/E  H Fe(II)-binding triad is
incompletely conserved, for example in JARID2 (pre-
dicted to have only one conserved His residue), KDM7C
(HxD  Y), and Hairless (CxE  H) [6,62,69]. It is possi-
ble that these enzymes bind Fe(II) with only two resi-
dues, as supported by FIH mutagenesis studies [70], or
that residues in unanticipated regions are involved in
metal chelation. Interestingly, biochemical and crystallo-
graphic studies reveal that these proposed ‘pseudo’
enzymes may still bind histones. For example, KDM7C
binds H3K4me3/2 in a manner related to its PHD domain
[62,71], and Hairless is proposed to have KDM activity
acting on H3K9me2/1 [69]. Further, there are reports of
KDM7C catalytic activity on H3K9me2 via protein ki-
nase A-dependent phosphorylation and demethylation of
ARID5B [72,73].
Future perspectives
Since the identification of the JmjC domain in JARID2
(Jumonji), there have been significant advances in the
assignment of biochemical and biological functions for
the JmjC oxygenases. Their now established roles in
chromatin biology and other aspects of epigenetic regu-
lation means that several JmjC KDMs are of interest from
a therapeutic perspective, particularly for cancer treat-
ment. Many human JmjC proteins are assigned catalytic
roles as protein oxygenases, with a notable exception
being TYW5, which acts on tRNA. While most of the
human JmjC KDMs act on histones, there is the possi-
bility that they can act on non-histone proteins, as appar-
ently do most JmjC hydroxylases. Crystallographic
analyses have revealed structural differences between
the KDMs and hydroxylases, which are of value in pre-
dicting functional assignments of uncharacterized JmjC
oxygenases. To date, relatively few structures of JmjC
oxygenases with substrates have been reported, and none
with intact protein substrates. Given the size and com-
plexity of JmjC oxygenases and their associated sub-
strates, future efforts can focus on obtaining such
structures, which are of particular interest to research
aiming to understand the roles of the JmjC oxygenases
in the modification of nucleosomes and translational
machinery. Biochemical and structural characterization
of atypical members of the JmjC subfamily, including
potential ‘pseudo’ enzymes, like JARID2, may be of
interest, especially since the history of 2OG oxygenases
suggests that unexpected reactions and biological roles
may emerge.
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